Indoco Remedies gains final ANDA approval for Rivaroxaban Tablets USP, 2.5 mg, 10 mg, 15 mg and 20 mg Read more
Cohance Lifesciences announces ₹230 mn investment and progress on cGMP Oligonucleotide facility at Hyderabad Read more
Panel Discussion: Building a high-value pharma destination: Making Chandigarh–Baddi investor-ready Read more